ARCHIVED: MD Anderson, Cayman Chemical, and Fannin Innovation Studio form therapeutics company
ACF Pharmaceuticals to explore the potential of novel, small molecule anti-cancer agents
MD Anderson News Release 09/15/2015
The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC. The pre-clinical therapeutics company is dedicated to discovering and developing novel small molecule inhibitors for the treatment of a variety of inflammation-induced...
ARCHIVED: MD Anderson to host evening fun run supporting skin cancer research
MD Anderson News Release 08/26/2015
Runners and walkers will soon hit the streets for the eighth annual AIM for the CURE Melanoma...
ARCHIVED: Moon Shots Program researchers to contribute to new Stand Up to Cancer Dream Teams
MD Anderson experts chosen for collaborative efforts against lung, ovarian cancer
MD Anderson News Release 04/20/2015
<...
ARCHIVED: Banner MD Anderson Cancer Center Opens
State-of-the-art facility is housed on the Banner Gateway campus
MD Anderson News Release 09/26/11
Banner MD Anderson Cancer Center, a unique collaboration between Banner Health and The University of Texas MD Anderson Cancer Center, opens today, ushering in a new era of unprecedented cancer care in Arizona. Banner MD Anderson joins Arizona's leading health care provider with the nation's leading...